How New Dosage Forms Prolong the Lifecycle of Mature Products

An age-old problem of the pharmaceutical industry is what to do if product sales are dropping or are anticipated to drop. How can you revitalise an ageing product, boost brand loyalty and recapture interest? One approach is to develop existing APIs into one or more alternative dosage forms. This article has been written by Dr Thomas Hein, SVP Commercial and Regulatory Affairs at HERMES PHARMA and been published in International Pharmaceutical Industry (IPI). It looks at the benefits of user-friendly dosage forms and what they offer to the pharmaceutical industry.